Pravin Dugel - May 3, 2022 Form 4 Insider Report for IVERIC bio, Inc. (ISEE)

Role
President
Signature
Todd Anderman, as Attorney-in-Fact for Pravin U. Dugel
Stock symbol
ISEE
Transactions as of
May 3, 2022
Transactions value $
$0
Form type
4
Date filed
5/5/2022, 06:02 PM
Previous filing
Apr 5, 2022
Next filing
Nov 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISEE Common Stock Options Exercise $0 +4.31K +3.93% $0.00 114K May 3, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISEE Restricted Stock Units Options Exercise $0 -4.31K -25% $0.00 12.9K May 3, 2022 Common Stock 4.31K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units.
F2 On May 3, 2021, the Reporting Person was granted 17,250 restricted stock units, which vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan.